Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

被引：2
|
作者：
Diamond, Eli L. [1 ]
Durham, Benjamin [2 ]
Dogan, Ahmet [3 ]
Yabe, Mariko [4 ]
Petrova-Drus, Kseniya [3 ]
Rampal, Raajit K. [5 ]
Ulaner, Gary [6 ]
Lacouture, Mario [7 ]
Rotemberg, Veronica [7 ]
Covey, Anne [2 ]
Brody, Lynn [8 ]
Abdel-Wahab, Omar [9 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY USA
[6] Hoag Family Canc Inst, Newport Beach, CA USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY USA
[8] MSKCC, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase 2 Trial of Single-Agent Cobimetinib for Adults With Histiocytic Disorders: Interim Results
    Diamond, Eli L.
    Durham, Benjamin H.
    Dogan, Ahmet
    Hyman, David M.
    Rampal, Raajit
    Ulaner, Gary
    Brody, Lynn
    Abdel-Wahab, Omar
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S5
  • [2] Phase 2 Trial of Single-Agent Cobimetinib for Adults with BRAF V600-Mutant and Wild-Type Histiocytic Disorders
    Diamond, Eli L.
    Durham, Benjamin H.
    Dogan, Ahmet
    Hyman, David M.
    Rampal, Raajit K.
    Ulaner, Gary
    Brody, Lynn
    Abdel-Wahab, Omar
    BLOOD, 2017, 130
  • [3] Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma
    Rassnick, K. M.
    Moore, A. S.
    Russell, D. S.
    Northrup, N. C.
    Kristal, O.
    Bailey, D. B.
    Flory, A. B.
    Kiselow, M. A.
    Intile, J. L.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2010, 24 (06) : 1528 - 1531
  • [4] Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
    Bartlett, Nancy L.
    Costello, Brian A.
    LaPlant, Betsy R.
    Ansell, Stephen M.
    Kuruvilla, John G.
    Reeder, Craig B.
    Thye, Lim S.
    Anderson, Daniel M.
    Krysiak, Kilannin
    Ramirez, Cody
    Qi, Jing
    Siegel, Barry A.
    Griffith, Malachi
    Griffith, Obi L.
    Gomez, Felicia
    Fehniger, Todd A.
    BLOOD, 2018, 131 (02) : 182 - 190
  • [5] RAF-Independent MEK Mutations Drive Histiocytic Neoplasms In Vivo and Are Sensitive to Single-Agent ERK Inhibition in Patients
    Durham, Benjamin H.
    Singer, Michael E.
    Benbarche, Salima
    Erickson, Caroline
    Rahman, Jahan
    Solit, David B.
    Witkowski, Matthew
    Rosen, Neal
    Abdel-Wahab, Omar
    Diamond, Eli L.
    BLOOD, 2022, 140 : 1098 - 1100
  • [6] Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer
    Markman, M
    Webster, K
    Zanotti, K
    Kulp, B
    Peterson, G
    Belinson, J
    GYNECOLOGIC ONCOLOGY, 2003, 90 (03) : 593 - 596
  • [7] A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
    Garzon, Ramiro
    Savona, Michael
    Baz, Rachid
    Andreeff, Michael
    Gabrail, Nashat
    Gutierrez, Martin
    Savoie, Lynn
    Mau-Sorensen, Paul Morten
    Wagner-Johnston, Nina
    Yee, Karen
    Unger, Thaddeus J.
    Saint-Martin, Jean-Richard
    Carlson, Robert
    Rashal, Tami
    Kashyap, Trinayan
    Klebanov, Boris
    Shacham, Sharon
    Kauffman, Michael
    Stone, Richard
    BLOOD, 2017, 129 (24) : 3165 - 3174
  • [8] A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma
    Sborov, Douglas W.
    Nuovo, Gerard J.
    Stiff, Andrew
    Mace, Thomas
    Lesinski, Gregory B.
    Benson, Don M., Jr.
    Efebera, Yvonne A.
    Rosko, Ashley E.
    Pichiorri, Flavia
    Grever, Michael R.
    Hofmeister, Craig C.
    CLINICAL CANCER RESEARCH, 2014, 20 (23) : 5946 - 5955
  • [9] A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma
    Kreisl, Teri N.
    Zhang, Weiting
    Odia, Yazmin
    Shih, Joanna H.
    Butman, John A.
    Hammoud, Dima
    Iwamoto, Fabio M.
    Sul, Joohee
    Fine, Howard A.
    NEURO-ONCOLOGY, 2011, 13 (10) : 1143 - 1150
  • [10] VINCRISTINE SULFATE AS SINGLE-AGENT CHEMOTHERAPY IN A DOG AND A CAT WITH MALIGNANT NEOPLASMS
    HAHN, KA
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1990, 197 (04) : 504 - 506
12345